This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Glenn, C. L. Articles by Morris, B. J. Search for Related Content PubMed PubMed Citation Articles by Glenn, C. L. Articles by Morris, B. J. Related Collections Clinical genetics Other hypertension

(Hypertension. 1999;33:927-932.)
© 1999 American Heart Association, Inc.

Scientific Contributions

Different Frequencies of Inducible Nitric Oxide Synthase Genotypes in Older Hypertensives

Cheryl L. Glenn; William Y. S. Wang; Brian J. Morris

From the Hypertension Gene Laboratory, Department of Physiology and Institute for Biomedical Research, The University of Sydney (Australia).

Correspondence to Brian J. Morris, DSc, Hypertension Gene Laboratory, Department of Physiology and Institute for Biomedical Research, Bldg F13, The University of Sydney, NSW 2006, Australia. E-mail brianm{at}physiol.usyd.edu.au

Abstract—A locus for essential hypertension has been found recently on chromosome 17 in the general vicinity of the inducible nitric oxide synthase (iNOS) gene (NOS2A at 17cen-q11.2). We therefore tested NOS2A markers for association and linkage with hypertension in affected Australian Anglo-Caucasians. Patients for the association study (n=112) were from our cohort of hypertensives (systolic/diastolic=175±25 SD/112±19 mm Hg) who were the offspring of 2 hypertensive parents; control subjects (n=164) were normotensives whose parents were both normotensive. The linkage study involved 156 hypertensive sib-pairs. Genotypes for an 8-allele pentameric repeat located 2.6 kb upstream of NOS2A and of a biallelic tetranucleotide repeat 0.7 kb upstream were determined by polymerase chain reaction and automated gene scan analysis. In the association study, the frequency of the minor allele of the biallelic marker was 0.18 in the hypertensives and 0.14 in the normotensives (²_{1 df}=1.1, P=0.3). Allele frequencies for the multiallelic marker were also similar in each group (² _{7 df}=9.8, P=0.2). Furthermore, no genotypic differences in blood pressure were apparent. In the sib-pair study, SPLINK APM, and MAPMAKERS/SIBS did not indicate excess allele sharing. We also examined genotype as a function of age. In the younger (< 60 years) hypertensives as well as younger or older normotensives, genotype and allele frequency of the biallelic marker was similar (0.12 to 0.14). However, in hypertensives 60 years of age, frequency of the minor allele was 0.28 (²=7.4, P=0.006). Homozygotes for this allele were rare. Frequency of heterozygotes was 0.19 for normotensives but 0.39 for the older hypertensives (²=8.0, P=0.018) and was 0.40 for hypertensive sibs 60 years of age with a diastolic pressure 100 mm Hg. Furthermore, homozygotes for the major allele were 7 years younger than heterozygotes (P=0.05 by ANOVA). In conclusion, the present study shows (1) no evidence for a role of NOS2A in hypertension and (2) a genotypic difference in frequency of a NOS2A promoter variant in older hypertensives, seen in 2 different cohorts. A possible interpretation of the latter observation is that NOS2A genotype could affect longevity, at least in patients at high risk by having moderate to severe hypertension.

Key Words: whites • hypertension, essential • nitric oxide synthase • genetics, biochemical • polymerase chain reaction • linkage (genetics) • survival